Published in Ann Surg on January 01, 2002
Panhematin provides a therapeutic benefit in experimental pancreatitis. Gut (2010) 2.23
Sterile inflammatory response in acute pancreatitis. Pancreas (2012) 1.15
Caspase-1 is hepatoprotective during trauma and hemorrhagic shock by reducing liver injury and inflammation. Mol Med (2011) 0.95
The clinical course of acute pancreatitis and the inflammatory mediators that drive it. Int J Inflam (2012) 0.94
Therapeutic effects of caspase-1 inhibitors on acute lung injury in experimental severe acute pancreatitis. World J Gastroenterol (2007) 0.93
Preparation method of an ideal model of multiple organ injury of rat with severe acute pancreatitis. World J Gastroenterol (2007) 0.92
Use of gene expression profiles in cells of peripheral blood to identify new molecular markers of acute pancreatitis. Arch Surg (2008) 0.91
The importance of interleukin 18, glutathione peroxidase, and selenium concentration changes in acute pancreatitis. Dig Dis Sci (2004) 0.86
Necro-inflammatory response of pancreatic acinar cells in the pathogenesis of acute alcoholic pancreatitis. Cell Death Dis (2013) 0.86
Epidural anaesthesia restores pancreatic microcirculation and decreases the severity of acute pancreatitis. World J Gastroenterol (2006) 0.85
Zerumbone attenuates the severity of acute necrotizing pancreatitis and pancreatitis-induced hepatic injury. Mediators Inflamm (2012) 0.83
Roles of caspase 1 and extracellular signal-regulated kinase in inflammation-induced inhibition of lacrimal gland protein secretion. Invest Ophthalmol Vis Sci (2008) 0.83
Immunomodulation in surgical practice. HPB (Oxford) (2006) 0.83
Caspase inhibitors attenuate superantigen-induced inflammatory cytokines, chemokines, and T-cell proliferation. Clin Diagn Lab Immunol (2004) 0.81
Immunomodulatory therapies for acute pancreatitis. World J Gastroenterol (2014) 0.81
Immune-modulating therapy in acute pancreatitis: fact or fiction. World J Gastroenterol (2014) 0.78
Protective effects of emodin combined with danshensu on experimental severe acute pancreatitis. Inflamm Res (2009) 0.77
Inhibition of the nucleotide-binding domain, leucine-rich containing family, pyrin-domain containing 3 inflammasome reduces the severity of experimentally induced acute pancreatitis in obese mice. Transl Res (2014) 0.76
Admission hematocrit: a simple, useful and early predictor of severe pancreatitis. Dig Dis Sci (2005) 0.76
Circulating nucleosomes as predictive markers of severe acute pancreatitis. J Intensive Care (2016) 0.76
Rosiglitazone attenuates the severity of hyperlipidemic severe acute pancreatitis in rats. Exp Ther Med (2013) 0.76
Paeoniflorin ameliorates acute necrotizing pancreatitis and pancreatitis‑induced acute renal injury. Mol Med Rep (2016) 0.75
Pathogenic mechanisms of pancreatitis. World J Gastrointest Pharmacol Ther (2017) 0.75
Caspase-1 inhibition alleviates acute renal injury in rats with severe acute pancreatitis. World J Gastroenterol (2014) 0.75
Infusion of Bone Marrow Mesenchymal Stem Cells Attenuates Experimental Severe Acute Pancreatitis in Rats. Stem Cells Int (2016) 0.75
The selective inhibition of type IV phosphodiesterase attenuates the severity of the acute pancreatitis in rats. Dig Dis Sci (2009) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science (1995) 11.38
Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol (1982) 10.99
Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell (1995) 9.11
Structure and mechanism of interleukin-1 beta converting enzyme. Nature (1994) 4.44
Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology (1986) 3.95
Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann N Y Acad Sci (1998) 3.62
Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol (1998) 3.04
The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg (1998) 2.84
Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci U S A (1989) 2.73
Natural course of acute pancreatitis. World J Surg (1997) 2.48
Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med (1998) 2.47
Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br J Surg (1999) 2.38
MedCalc: a new computer program for medical statistics. Comput Methods Programs Biomed (1995) 2.21
Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol (1999) 2.03
Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut (2000) 1.86
Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J Immunol (2000) 1.80
Clinical relevance of caspase-1 activated cytokines in acute pancreatitis: high correlation of serum interleukin-18 with pancreatic necrosis and systemic complications. Crit Care Med (2001) 1.79
The physiologic basis for anticytokine clinical trials in the treatment of sepsis. J Am Coll Surg (1998) 1.57
Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery (1995) 1.49
Acute pancreatitis and cytokines: "second attack" by septic complication leads to organ failure. Pancreas (1998) 1.48
Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-alpha polyclonal antibody. Am J Surg (1994) 1.45
Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg (1995) 1.41
Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis. Gastroenterology (1997) 1.38
Anti-TNFalpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg (1996) 1.33
Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg (1996) 1.28
Pathophysiologic role of oxygen free radicals in acute pancreatitis: initiating event or mediator of tissue damage? Ann Surg (2000) 1.26
Interleukin-1 beta converting enzyme inhibition blocks progression of type II collagen-induced arthritis in mice. Cytokine (1996) 1.17
Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann Surg (1996) 1.17
Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Surgery (1996) 1.13
Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis. Br J Surg (1996) 1.11
Intrapancreatic interleukin-1beta gene expression by specific leukocyte populations during acute pancreatitis. J Surg Res (1996) 1.08
Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme (ICE). J Interferon Cytokine Res (1997) 1.05
Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model. Crit Care Med (1995) 1.03
The role of polymorphonuclear leukocytes and oxygen-derived free radicals in experimental acute pancreatitis: mediators of local destruction and activators of inflammation. FEBS Lett (1999) 1.02
Differential effects of caspase-1/interleukin-1beta-converting enzyme on acinar cell necrosis and apoptosis in severe acute experimental pancreatitis. Lab Invest (2001) 1.00
The physiologic consequences of macrophage pacification during severe acute pancreatitis. Shock (1998) 0.99
ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Curr Biol (1996) 0.90
Systemic lymphocyte activation modulates the severity of diet-induced acute pancreatitis in mice. Pancreas (1999) 0.87
Treatment of sepsis: past and future avenues. Drugs (1999) 0.83
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med (2006) 7.42
Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology (2004) 4.24
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood (2008) 3.03
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. Blood (2013) 3.03
Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity. Immunity (2011) 2.87
Cooperative epigenetic modulation by cancer amplicon genes. Cancer Cell (2010) 2.43
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet (2012) 2.07
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood (2008) 1.97
Cryoprobe biopsy increases the diagnostic yield in endobronchial tumor lesions. J Thorac Cardiovasc Surg (2010) 1.96
Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol (2005) 1.96
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression. Hum Pathol (2007) 1.95
Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma. Blood (2009) 1.92
Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J Pathol (2010) 1.91
Effects of ventilation with 100% oxygen during early hyperdynamic porcine fecal peritonitis. Crit Care Med (2008) 1.85
Mediastinal (thymic) large B-cell lymphoma: where do we stand? Lancet Oncol (2002) 1.77
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood (2013) 1.71
Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. Arch Surg (2007) 1.69
Leptin gene expression in human preadipocytes is switched on by maturation-induced demethylation of distinct CpGs in its proximal promoter. J Biol Chem (2002) 1.63
Comparison of carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury. Intensive Care Med (2011) 1.60
Effects of intravenous sulfide during resuscitated porcine hemorrhagic shock*. Crit Care Med (2012) 1.58
Severe acute pancreatitis: Clinical course and management. World J Gastroenterol (2007) 1.55
Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood (2002) 1.53
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood (2008) 1.47
Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphoma. Haematologica (2011) 1.46
Molecular imaging of proliferation in malignant lymphoma. Cancer Res (2006) 1.46
Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line. Blood (2004) 1.46
Treatment of pancreatic cancer: challenge of the facts. World J Surg (2003) 1.45
Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia (2009) 1.44
Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma. Cancer Res (2009) 1.42
Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil. Clin Cancer Res (2003) 1.40
Effects of Hyperoxia and Mild Therapeutic Hypothermia During Resuscitation From Porcine Hemorrhagic Shock. Crit Care Med (2016) 1.40
[Private health care in Stockholm is threatened]. Lakartidningen (2002) 1.39
KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma. Blood (2010) 1.38
STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL). Oncotarget (2013) 1.35
MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas. Mod Pathol (2002) 1.34
Characteristics of infection with Candida species in patients with necrotizing pancreatitis. World J Surg (2001) 1.33
Imaging prostate cancer with 11C-choline PET/CT. J Nucl Med (2006) 1.33
Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours. Gut (2010) 1.32
Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations. Haematologica (2008) 1.32
FOXO1 is a tumor suppressor in classical Hodgkin lymphoma. Blood (2012) 1.31
Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res (2013) 1.27
Foxp3-expressing CD103+ regulatory T cells accumulate in dendritic cell aggregates of the colonic mucosa in murine transfer colitis. Am J Pathol (2006) 1.27
Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma. Blood (2005) 1.24
Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression. Blood (2004) 1.23
Human IL4I1 is a secreted L-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation. Blood (2007) 1.23
Pancreatic stellate cells are an important source of MMP-2 in human pancreatic cancer and accelerate tumor progression in a murine xenograft model and CAM assay. J Cell Sci (2007) 1.22
ADAM12 induces actin cytoskeleton and extracellular matrix reorganization during early adipocyte differentiation by regulating beta1 integrin function. J Cell Sci (2003) 1.21
Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma. Blood (2002) 1.21
Identification of novel Myc target genes with a potential role in lymphomagenesis. Nucleic Acids Res (2004) 1.20
A new missense mutation in the leptin gene causes mild obesity and hypogonadism without affecting T cell responsiveness. J Clin Endocrinol Metab (2010) 1.19
Expression of TRAIL and TRAIL receptors in colon carcinoma: TRAIL-R1 is an independent prognostic parameter. Clin Cancer Res (2002) 1.18
Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization. Oncogene (2003) 1.18
Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer. BJU Int (2007) 1.18
Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor System. Clin Chem Lab Med (2004) 1.17
Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Tumour Biol (2006) 1.16
Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma. Haematologica (2008) 1.15
Quantifying telomere lengths of human individual chromosome arms by centromere-calibrated fluorescence in situ hybridization and digital imaging. Am J Pathol (2003) 1.14
Identification of tobacco-derived compounds in human pancreatic juice. Chem Res Toxicol (2002) 1.13
The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. Br J Haematol (2005) 1.12
Role of early multisystem organ failure as major risk factor for pancreatic infections and death in severe acute pancreatitis. Clin Gastroenterol Hepatol (2006) 1.12
VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome. Blood (2003) 1.10
Early assessment of therapy response in malignant lymphoma with the thymidine analogue [18F]FLT. Eur J Nucl Med Mol Imaging (2007) 1.10
Pancreatic fungal infection. Pancreas (2003) 1.10
Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis. Eur J Immunol (2003) 1.09
Molecular characterization of putative chordoma cell lines. Sarcoma (2010) 1.09
Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study. Ann Surg (2007) 1.09
Effects of immunosuppressive and immunostimulative treatment on pancreatic injury and mortality in severe acute experimental pancreatitis. Pancreas (2006) 1.08
TRAIL-induced apoptosis is preferentially mediated via TRAIL receptor 1 in pancreatic carcinoma cells and profoundly enhanced by XIAP inhibitors. Clin Cancer Res (2010) 1.08
Loss of Drop1 expression already at early tumor stages in a wide range of human carcinomas. Int J Cancer (2008) 1.08
First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidine. J Nucl Med (2008) 1.08
Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network. J Hematop (2009) 1.07
Potential clinical implications of BRAF mutations in histiocytic proliferations. Oncotarget (2014) 1.07
POU5F1P1, a putative cancer susceptibility gene, is overexpressed in prostatic carcinoma. Prostate (2010) 1.06
Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status. Genes Chromosomes Cancer (2009) 1.06
No evidence of IGH-MALT1 translocation in the Ma-1 cell line. Genes Chromosomes Cancer (2013) 1.05
CC-chemokine activation in acute pancreatitis: enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications. Intensive Care Med (2003) 1.04
Endotoxemia and endotoxin tolerance in patients with ARDS. Langenbecks Arch Surg (2008) 1.04
Identification of c-FLIP(L) and c-FLIP(S) as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells. Gut (2010) 1.04
Pancreatic injury in severe trauma: early diagnosis and therapy improve the outcome. Dig Surg (2002) 1.03
Natural history of necrotizing pancreatitis. Pancreatology (2003) 1.03
Long-term experience on surgical treatment of alveolar echinococcosis. Langenbecks Arch Surg (2008) 1.01
Early complications after laparoscopic gastric bypass surgery: results from the Scandinavian Obesity Surgery Registry. Ann Surg (2014) 1.00
Hyperinsulinemia induces insulin resistance on glucose and lipid metabolism in a human adipocytic cell line: paracrine interaction with myocytes. J Clin Endocrinol Metab (2008) 0.99
Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial. Crit Care (2009) 0.98
Mechanisms of parenchymal injury and signaling pathways in ectatic ducts of chronic pancreatitis: implications for pancreatic carcinogenesis. Lab Invest (2009) 0.98
AID expression identifies interfollicular large B cells as putative precursors of mature B-cell malignancies. Blood (2005) 0.98
TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections. Gastroenterology (2002) 0.98
Pancreatic cancer--low survival rates. Dtsch Arztebl Int (2008) 0.98
Clinical relevance of imaging proliferative activity in lung nodules. Eur J Nucl Med Mol Imaging (2004) 0.97
Activating immunity in the liver. II. IFN-beta attenuates NK cell-dependent liver injury triggered by liver NKT cell activation. J Immunol (2002) 0.97
Clinicopathologic correlations of genomic gains and losses in follicular lymphoma. J Clin Oncol (2002) 0.96
Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. Cancer Res (2006) 0.96
Adrenomedullin binding improves catecholamine responsiveness and kidney function in resuscitated murine septic shock. Intensive Care Med Exp (2013) 0.96
Nck adaptors are positive regulators of the size and sensitivity of the T-cell repertoire. Proc Natl Acad Sci U S A (2010) 0.95
NF-κB signaling in prostate cancer: a promising therapeutic target? World J Urol (2011) 0.95